Corticosteroid Use for Drug‑Allergy Reactions in Patients with Heart Failure
1. Selection and Dosing of Systemic Corticosteroids
- Intravenous methylprednisolone 1–2 mg/kg/day divided every 6 h is recommended for severe or prolonged allergic reactions in patients with heart failure. The dose should be continued for 2–3 days after discharge. 1
- Oral prednisone 0.5 mg/kg is appropriate for less critical drug‑allergy episodes in this population. Treatment duration is also 2–3 days post‑hospitalization. 2
- If a patient has a documented allergy to methylprednisolone or hydrocortisone, betamethasone or dexamethasone may be used as safer alternatives. 1
2. Role of Corticosteroids in Acute Anaphylaxis
- Epinephrine intramuscular injection (0.3–0.5 mg of 1:1000 solution) remains the first‑line therapy for anaphylaxis, irrespective of heart‑failure status; corticosteroids are not a substitute. 3
- Corticosteroids serve only as adjunctive therapy because their anti‑inflammatory effect is delayed; they do not replace epinephrine in the acute phase. 2
- The primary indication for adjunctive steroids is the prevention of biphasic or prolonged reactions. 3
3. Monitoring and Safety in Heart‑Failure Patients
- Corticosteroids can promote sodium and fluid retention, potentially worsening heart‑failure symptoms; therefore, close monitoring for signs of volume overload is required. 4
- Daily weight checks and assessment for congestion should be performed while patients receive steroids. 5
- Diuretic doses may need adjustment in response to steroid‑induced fluid retention. 5
- Avoid prolonged courses or unnecessary high‑dose corticosteroids to minimize the risk of cardiac decompensation. 6
4. Drug Interactions and Continuation of Guideline‑Directed Heart‑Failure Therapy
- Corticosteroids may interact with heart‑failure medications, especially by enhancing fluid retention; clinicians should be vigilant. 4
- Do not discontinue guideline‑directed heart‑failure therapies (ACE‑I/ARB, β‑blocker, mineralocorticoid receptor antagonist) during acute corticosteroid treatment. 7
5. Practical Treatment Protocols
5.1 Severe Anaphylaxis (including patients with heart failure)
5.2 Mild‑to‑Moderate Reactions
- Oral prednisone 0.5 mg/kg for 2–3 days. 9
- H1 and H2 antihistamines as needed. 9
- Close observation to detect any progression to severe reaction. 9
6. Critical Safety Warnings
- Corticosteroids must never be used as monotherapy for anaphylaxis; epinephrine is essential. 3
- Prophylactic corticosteroids should not be administered indiscriminately for transfusion reactions. 10
- In patients with severe heart failure (systolic BP < 80 mm Hg), prioritize hemodynamic stabilization before considering corticosteroid therapy. 7